|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
||
|
a)
|
Name
|
Dr M M
Slaoui
|
|
|
b)
|
Position/status
|
Chairman,
Global Vaccines
|
|
|
c)
|
Initial
notification/
amendment
|
Initial
notification
|
|
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction
monitor
|
||
|
a)
|
Name
|
GlaxoSmithKline
plc
|
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||
|
a)
|
Description of the
financial instrument
|
GlaxoSmithKline
plc American Depositary Shares ('ADSs')
ISIN:
US37733W1053
|
|
|
b)
|
Nature of the transaction
|
An
increase of 22 ADS following the notional allocation of ADSs on 3
November 2016, at a price of $38.74 per ADS, as a result of the
revaluation of the cash element of the notional investment held
within the GSK 401(K) plan.
|
|
|
c)
|
Price(s) and
volume(s)
|
Price(s)
|
Volume(s)
|
|
$38.74
|
22
|
||
|
d)
|
Aggregated information
Aggregated volume Price
|
n/a
(single transaction)
|
|
|
e)
|
Date of
the transaction
|
2016-11-03
|
|
|
f)
|
Place of the transaction
|
n/a
|
|
|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
||
|
a)
|
Name
|
Dr K
Slaoui
|
|
|
b)
|
Position/status
|
PCA of
Dr M M Slaoui (Chairman, Global Vaccines)
|
|
|
c)
|
Initial
notification/
amendment
|
Initial
notification
|
|
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction
monitor
|
||
|
a)
|
Name
|
GlaxoSmithKline
plc
|
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||
|
a)
|
Description of the
financial instrument
|
GlaxoSmithKline
plc American Depositary Shares ('ADSs')
ISIN:
US37733W1053
|
|
|
b)
|
Nature of the transaction
|
An
increase of 3 ADS following the notional allocation of ADSs on 3
November 2016, at a price of $38.74 per ADS, as a result of the
revaluation of the cash element of the notional investment held
within the GSK 401(K) plan.
|
|
|
c)
|
Price(s) and
volume(s)
|
Price(s)
|
Volume(s)
|
|
$38.74
|
3
|
||
|
d)
|
Aggregated information
Aggregated volume Price
|
n/a
(single transaction)
|
|
|
e)
|
Date of
the transaction
|
2016-11-03
|
|
|
f)
|
Place of the transaction
|
n/a
|
|